Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)
Karim S. Fizazi, A. Maillard, Nicolas Penel, G. Baciarello, Djelila Allouache, Gedske Daugaard and 14 more
- Rank
- 50 of 4,622
- Percentile
- top 1.1%
- Where
- Annals of Oncology, 2019
- Citations
- 246
From the 2019 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.